✔ 100% Authentic Product
👁️ Currently Viewing 598
Reucent XR 15mg Tablet 1 Strip
Upadacitinib is a JAK inhibitor that works by interfering with the intracellular signaling of cytokines and growth factors, which are involved in immune system processes and the development of rheumatoid arthritis. It prevents the activation of signal transducers and activators of transcription (STATs), which are responsible for gene expression in immune cells.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cash on Delivery - All over Bangladesh
Regular Delivery - 12-24 Hours, Dhaka City*- Regular Delivery - 24-48 Hours, All Over Bangladesh*
ফ্রি ডেলিভারি! - ১৪৯৯ টাকা+ অর্ডারে ঢাকা
শহরে ।
✅ Description:
- Reucent XR is used for treating adults with moderate to severely active rheumatoid arthritis, particularly when there has been an inadequate response or intolerance to methotrexate.
✔️ Side Effects:
Common side effects include:
- Upper respiratory tract infections.
- Nausea.
- Cough.
- Fever (pyrexia).
✔️ Dosage and Administration:
- The recommended dose is 15 mg once daily.
- It can be taken either monotherapy or in combination with methotrexate or other non-biologic disease-modifying antirheumatic drugs (DMARDs).
- Avoid initiation or interruption if:
- Absolute lymphocyte count is below 500 cells/mm³.
- Absolute neutrophil count is below 1000 cells/mm³.
- Hemoglobin level is below 8 g/dL.
- Pediatric Use: Safety and efficacy in children (aged 0-18 years) have not been established.
- Hepatic Impairment: Not recommended for patients with severe hepatic impairment.
✔️ Overdose Effects:
- In clinical trials, doses up to 60 mg extended-release daily showed adverse events similar to lower doses.
- Overdose: Monitor for signs of adverse reactions and treat appropriately. Reucent XR is largely eliminated within 24 hours of dosing.
✔️ Interactions:
- Strong CYP3A4 Inhibitors (e.g., ketoconazole) increase Reucent XR exposure. Use with caution in patients receiving chronic treatment with such inhibitors.
- Strong CYP3A4 Inducers (e.g., rifampin) decrease Reucent XR exposure, potentially reducing its therapeutic effect. Avoid co-administration with strong CYP3A4 inducers.
✔️ Pregnancy & Lactation:
- Pregnancy: Limited data are available on human use during pregnancy, but based on animal studies, Reucent XR may adversely affect a developing fetus.
- Breastfeeding: It is advised not to breastfeed while using Reucent XR.
✔️ Precautions & Warnings:
- Serious Infections: Avoid use in patients with active, serious infections.
- Malignancy: Carefully consider the risks and benefits before starting treatment in patients with a known malignancy.
- Thrombosis: Evaluate the risks of treatment in patients at higher risk of blood clot formation.
- Gastrointestinal Perforations: Use with caution in patients who are at increased risk.
- Laboratory Monitoring: Monitor lymphocytes, neutrophils, hemoglobin, liver enzymes, and lipids.
- Embryo-Fetal Toxicity: Advise females of reproductive potential about the potential risk to a fetus and to use effective contraception during treatment.
- Vaccinations: Avoid use with live vaccines.
✔️ Storage Conditions:
- Store below 25°C.
- Keep away from light and out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.
